Suspension of trading

Valuation Durect

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2025-09-10 EDT			5-day change	1st Jan Change
1.910 ^USD	-1.04%		-.--%	-

25-09-11	Bausch Health Companies Inc. completed the acquisition of DURECT Corporation.	CI
25-09-11	Bausch Health Completes US$63 Million Durect Acquisition, Adds Breakthrough Hepatitis Therapy to Pipeline	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Market Cap ¹	731	420.6	224.3	78.84	17.6	23.28
Change	-	-42.46%	-46.67%	-64.85%	-77.68%	32.29%
Enterprise Value (EV) ¹	693.1	405.7	178.8	58.62	8.665	13.68
Change	-	-41.47%	-55.93%	-67.21%	-85.22%	57.93%
P/E Ratio	-31.7x	-709x	-6.12x	-2.23x	-0.49x	-2.74x
PBR	32.5x	10.5x	3.88x	3.16x	1.21x	2.55x
PEG	-	7.3x	-0x	0.6x	0x	0x
Capitalization / Revenue	24.7x	14x	16x	4.09x	2.06x	11.5x
EV / Revenue	23.4x	13.5x	12.8x	3.04x	1.01x	6.74x
EV / EBITDA	-35.8x	-32.9x	-5.26x	-1.68x	-0.24x	-0.73x
EV / EBIT	-35.3x	-32.2x	-5.22x	-1.67x	-0.23x	-0.72x
EV / FCF	43x	-8.32x	-20x	-4.29x	-0.41x	-1.58x
FCF Yield	2.32%	-12%	-5%	-23.3%	-242%	-63.4%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-1.2	-0.0292	-1.611	-1.551	-1.205	-0.2739
Distribution rate	-	-	-	-	-	-
Net sales ¹	29.56	30.11	13.98	19.28	8.548	2.031
EBITDA ¹	-19.36	-12.32	-33.98	-34.96	-36.85	-18.83
EBIT ¹	-19.65	-12.62	-34.27	-35.08	-36.88	-18.91
Net income ¹	-20.58	-0.582	-36.26	-35.33	-27.62	-8.324
Net Debt ¹	-37.85	-14.92	-45.51	-20.22	-8.934	-9.597
Reference price ²	38.000	20.700	9.859	3.460	0.590	0.750
Nbr of stocks (in thousands)	19,236	20,318	22,751	22,786	29,829	31,042
Announcement Date	3/5/20	3/5/21	3/8/22	3/8/23	3/28/24	3/27/25